Briefly, the cerebral cortex, cerebellum, corpus stniatum, and diencephalon were dissected under a dissecting microscope and the meninges were carefully removed. The tissues were triturated using 10-mI pipettes and were incubated in Ca , Mg -free Hank's balanced salt solution containing 0.1% trypsin for 25 mm in a shaking water bath. Trypsinization was terminated by adding at least an equal volume of CCM. The dissociated cells were filtered through a Nitex 210 followed by 130 (Tetko; Ehnsford, NY). The cell filtrates were centrifuged at 100 x g for 5 mm. The resulting cell pellets were re-suspended in fresh CCM and filtered through a Nitex 40. Cells were counted in a Coulter Counter and were then plated at a density of 4 x i0 cells/cm2 on canted culture flasks (Corning Glass Works; Corning, NY). Cultures were maintained in CCM at 37'C in a humidified atmosphere of 95% air/5% CO2 for 9-11 days until cultures had reached confluency.
The medium was changed after the third day and every other day thereafter.
Cultures enriched in astrocytes and oligodendrocytes were prepared by the method of McCarthy and de Vellis (19) with some modifications(31). Culture flasks were shaken on an orbital shaker at 250 rpm for 8-18 hr. the suspended cells were centrifuged, resuspended, and filtered through Nitex 40 and 20. Cells were plated at a final density of 3-5 x 104/chamber on four-chambered glass slides (Nunc; Naperville, IL). In culture, these cells developed into process-bearing astrocytes when grown in CCM and into oligodendrocytes when grown in CDM (29) . Culture flasks were shaken for an additional hr to remove residual process-bearing cells. Polygonal astrocytes adhering to cultune flasks were treated briefly with a solution of0.05% trypsin/0.53 mM EDTA.
The suspended cells were centrifuged, re-suspended, and filtered through Nitex 40. Cells were then plated at a density of 1-2 x 104/chamben on four-chambered glass slides and maintained in CCM. If necessary, medium was switched to astrocyte-CDM or CCM containing 1 mM dibutyryl cyclic AMP (dBcAMP) for up to 5 days. For short-term studies involving polygonal astrocytes, mixed glial cells prepared from neonatal rat brains were plated at low density onto chambered glass slides and were cultured for 3-5 days.
Antisera.
The preparation ofrabbit polydonal antibodies against porcine mMDH has been described previously (4). The specificity of the antiserum was confirmed by Western blot analysis as described (4). The anti-mMDH serum reacted with the mitochondrial form of the enzyme from pigs, chickens, and rats but not with the cytosolic form. This indicated that the anti-mMDH antibody was specific for the mitochondnial form of the enzyme. A2B5 hybnidoma cells(6)were obtained from the American Type Culture Collection (Bethesda, MD) and were used to prepare ascites fluid from Balb/c mice as described (21). The following antibodies were obtained from the indicated sources: mouse monoclonal anti-myelin basic protein (MBP) antibody from Boehninger Mannheim (Indianapolis, IN); mouse monoclonal anti-glial fibrillary acidic protein (GFAP)from Sigma; control ascitesfluid fromlG4(Costa Mesa, CA); rabbit anti-fibronectin from Chemicon (Temecula, CA); pre-immune rabbit serum from Sternbenger-Meyer (Jarrettsville, MD); and all fluorescein-conjugated secondary antibodies from Cappel(Durham, NC). Acetylatedlow-density lipoprotein conjugated to 1,1'dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (dil-acLDL), a fluorescent probe, was obtained from Biomedical Technologies (Stoughton, MA).
Immunocytochemistry.
To characterize purified glial cells, each type of cell culture was incubated with either monoclonal anti-GFAP (1:200) or anti-MBP (1:200). For the localization of A2B5 antigen, cultures were processed as described (6). Controls were incubated with the same dilution of control ascites fluid. For the double immunocytochemical localization of GFAP and mMDH, cells cultured on chambered glass sides were fixed in 4% para.formaldehyde in 20 mM PBS, pH 7.3, and permeabilized in 95 % ethanol for 5-10 mm at room temperature.
The slides were then successively: (a) incubated in 1% bovine serum albumin at 37'C for 30 mm; profiles within the cells. For each chamber on a glass slide, 10 randomly selected areas were counted using the fluorescent microscope.
For each ofthe four brain regions studied (cerebral cortex, cerebellum, corpus striatum, and diencephalon), data from at least three separate culture chambers were collected from three separate cultures. To prevent fading of fluorescence during observation, a 1:1 solution of sodium azide dissolved in PBS (50 g/liter) and glycerol (final concentration 50%) was applied to the slides (2).
Results

Cell Cultures
Purified cultures of polygonal astrocytes were virtually devoid of process-bearing cells ( Figure  1A) . These cultures consisted of more than 95% astrocytes, as determined by immunocytochemical staining with anti-GFAP ( Figure  1B) . Staining with dil-acLDL, a fluorescent probe that recognizes ac-LDL receptors (10), was virtually ib, inset) . In cultures enriched in processbearing astrocytes, the cells had long, slender processes emanating from phase-dark cell bodies ( Figure  1C ). The number ofcells that were GFAP positive progressively increased up to 70-80% when these cultures were maintained in CCM ( Figure  1D ). Process-bearing astrocytes were A2B5 positive (Figure id, inset) . Oligodendrocytes, with their characteristic highly branched processes, were major contaminants; these cells comprised up to 20% ofcells, as determined by imrnunocytochemical detection of MBP (data not shown). Less than 5% of the cells were positively stained with dil-acLDL (data not shown).
Oligodendrocytes grown in oligodendnocyte-CDM had processes emanating from aggregated cell bodies on scattered, phasebright round cell bodies ( Figure 1E ). These cultures were highly enriched in oligodendrocytes, as evidenced by almost uniform immunocytochemical staining with monoclonal anti-MBP ( Figure  iF) .
Immunocytochemistry
Almost all of the process-bearing astrocytes and oligodendrocytes from cerebral cortex showed uniformly intense anti-mMDH im- In contrast to the findings for process-bearing astrocytes on oligodendrocytes, the granular immunoreactivity to anti-mMDH within individual polygonal astrocytes varied from weakly to intensely positive ( Figure  3A) . In some GFAP-positive astrocytes, anti-mMDH immunofluorescence was present but barely detectable (Figure 3A, arrowhead) . Interestingly, some polygonal astrocytes were found to be negative for any anti-mMDH immunofluorescence (data not shown), although the presence of mMDH in amounts below the sensitivity of our immunocytochemical procedure cannot be ruled out. This variable pattern ofimmunoreactivity was observed for polygonal astrocytes cultured from diencephalon ( Figure  3A ), corpus stniatuni ( Figure  3C ), cerebral cortex (data not shown), and cerebellum (data not shown). As shown in Figure  3C , the anti-mMDH immunofluonescent pattern within the cell was arbitrarily rated as a weak/negative reaction, moderate reaction, on intense reaction. Cells having a staining intensity that fell between the moderate and intense groups in Figure 3C were also dassified within the intense group. This classification was utilized to determine the pattern of anti-mMDH immunoreactivity within polygonal astrocytes derived from various brain regions, as summarized in Figure 5 .
Variation in the intensity of anti-mMDH immunofluorescence did not seem to reflect a large variation in the number of mitochondria within individual cells. As shown in Figure 3D, (20, 33, 38) . However, we found no correlation between the intenunlikely. Therefore, our results suggest that this variable intensity sity of anti-GFAP immunoreactivity and anti-mMDH fluorescence (see Figure  3 ). Furthermore, there was no correlation between the 
